Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
The dying cells send signals to recipient tumor cells to increase aggressiveness, motility, and resistance to radiation or chemotherapy.
Two Novel Research grants from the Lupus Research Alliance boost the study of this complex disease.
Such analysis, researchers say, can help identify pathogen contact points between species, including pathogens causing human disease.
All-day National Science Foundation workshop showed Alabama researchers how to better compete for federal grants.
The award will support Higgins’ research at Oak Ridge National Laboratory, where he will use neutron beams to probe the internal structure of polymer films.
A neuron model of Parkinson’s disease and Lewy body dementias shows defects that could suggest treatments to halt or reverse cognitive impairments before the neurons die.
Frances Lund highlighted the need to do drug trials where the concentrations of inflammatory diseases are highest — the Southeast.
In Rome, Frances Lund will talk about the need to do drug trials where the concentrations of chronic inflammatory diseases are highest — the Southeast.
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients.
CNine Biosolutions is moving toward clinical testing of its UAB-licensed technology.